Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia

Recent studies suggest that microglia over‐expressing mutant human superoxide dismutase (mSOD1G93A) may contribute to motoneuron death in a transgenic mouse model of familial amyotrophic lateral sclerosis. To further assess the relative neurotoxicity of wild‐type microglia, mSOD1G93A microglia, and microglia over‐expressing wild‐type human SOD1, we used primary cultures of microglia and motoneurons in the presence and absence of lipopolysaccharide stimulation. Following activation with lipopolysaccharide, mSOD1G93A microglia released more nitric oxide, more superoxide, and less insulin‐like growth factor‐1 than wild‐type microglia. In microglia/motoneuron co‐cultures, mSOD1G93A microglia induced more motoneuron death and decreased neurite numbers and length compared with wild‐type microglia. Mutant SOD1G93A microglia also induced more motoneuron injury than microglia over‐expressing wild‐type human SOD1 in microglia/motoneuron co‐cultures. Motoneuron survival was inversely correlated with nitrate + nitrite concentrations in mSOD1G93A co‐cultures, suggesting the important role of nitric oxide in microglia‐induced motoneuron injury. Thus, relative to wild‐type microglia, mSOD1G93A microglia were more neurotoxic and induced more motoneuron injury than similarly treated wild‐type microglia.

[1]  L. Martin,et al.  Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase‐1 transgenic mice: Mechanisms of mitochondriopathy and cell death , 2007, The Journal of comparative neurology.

[2]  M. Mattson,et al.  Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain , 2007, NeuroMolecular Medicine.

[3]  S. Appel,et al.  Protective effects of an anti‐inflammatory cytokine, interleukin‐4, on motoneuron toxicity induced by activated microglia , 2006, Journal of neurochemistry.

[4]  S. Mckercher,et al.  Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis , 2006, Proceedings of the National Academy of Sciences.

[5]  G. Kollias,et al.  Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.

[6]  E. Bigio,et al.  Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  B. Pettmann,et al.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Appel,et al.  The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS , 2006, Molecular and Cellular Neuroscience.

[9]  A. Sik,et al.  Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis , 2006, Nature Neuroscience.

[10]  M. Shoji,et al.  Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis , 2005, Journal of the Neurological Sciences.

[11]  M. Schwartz,et al.  Activation of microglia by aggregated β-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective , 2005, Molecular and Cellular Neuroscience.

[12]  M. Schwartz,et al.  Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. , 2005, Molecular and cellular neurosciences.

[13]  B. Ransom,et al.  Increased cytotoxic potential of microglia from ALS‐transgenic mice , 2004, Glia.

[14]  W. Le,et al.  Activated Microglia Initiate Motor Neuron Injury by a Nitric Oxide and Glutamate‐Mediated Mechanism , 2004, Journal of neuropathology and experimental neurology.

[15]  E. Feldman,et al.  IGF-I prevents glutamate-induced motor neuron programmed cell death , 2004, Neurobiology of Disease.

[16]  Deanna L. Taylor,et al.  Microglia release activators of neuronal proliferation mediated by activation of mitogen‐activated protein kinase, phosphatidylinositol‐3‐kinase/Akt and delta–Notch signalling cascades , 2004, Journal of neurochemistry.

[17]  T. Siddique,et al.  Presence of dendritic cells, MCP‐1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue , 2004, Annals of neurology.

[18]  K. Hensley,et al.  Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. , 2004, Journal of Alzheimer's disease : JAD.

[19]  Minh N. H. Nguyen,et al.  Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.

[20]  F. Gage,et al.  Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model , 2003, Science.

[21]  R. Vos,et al.  Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis , 2003, The Lancet.

[22]  B. Liu,et al.  Synergistic Dopaminergic Neurotoxicity of the Pesticide Rotenone and Inflammogen Lipopolysaccharide: Relevance to the Etiology of Parkinson's Disease , 2003, The Journal of Neuroscience.

[23]  Kenji Nakanishi,et al.  SOCS-1 participates in negative regulation of LPS responses. , 2002, Immunity.

[24]  Hiroshi Nishimune,et al.  Motoneuron Death Triggered by a Specific Pathway Downstream of Fas Potentiation by ALS-Linked SOD1 Mutations , 2002, Neuron.

[25]  M. Strong,et al.  Activated microglia (BV-2) facilitation of TNF-α-mediated motor neuron death in vitro , 2002, Journal of Neuroimmunology.

[26]  A. Yoshimura,et al.  Involvement of Suppressor of Cytokine Signaling-3 as a Mediator of the Inhibitory Effects of IL-10 on Lipopolysaccharide-Induced Macrophage Activation1 , 2002, The Journal of Immunology.

[27]  P. Caroni,et al.  Accumulation of SOD1 Mutants in Postnatal Motoneurons Does Not Cause Motoneuron Pathology or Motoneuron Disease , 2002, The Journal of Neuroscience.

[28]  T. Morgan,et al.  Peroxynitrite Mediates Neurotoxicity of Amyloid β-Peptide1–42- and Lipopolysaccharide-Activated Microglia , 2002, The Journal of Neuroscience.

[29]  M. Strong,et al.  Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro. , 2002, Journal of neuroimmunology.

[30]  Wenjie Xie,et al.  Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson's Disease , 2001, The Journal of Neuroscience.

[31]  S. Appel,et al.  Parvalbumin overexpression alters immune‐mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis , 2001, Journal of neurochemistry.

[32]  S. Appel,et al.  Immune reactivity in a mouse model of familial ALS correlates with disease progression , 2001, Neurology.

[33]  Guy C. Brown,et al.  Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity , 2001, The Journal of Neuroscience.

[34]  H. Fathallah-Shaykh,et al.  Survival in a transgenic model of fals is independent of inos expression , 2001, Annals of neurology.

[35]  A. Pramatarova,et al.  Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor Impairment , 2001, The Journal of Neuroscience.

[36]  S. Barger,et al.  Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function , 2001, Journal of neurochemistry.

[37]  J. Pocock,et al.  Microglial signalling cascades in neurodegenerative disease. , 2001, Progress in brain research.

[38]  J. Holstege,et al.  Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression in Mice Causes Mitochondrial Vacuolization, Axonal Degeneration, and Premature Motoneuron Death and Accelerates Motoneuron Disease in Mice Expressing a Familial Amyotrophic Lateral Sclerosis Mutant SOD1 , 2000, Neurobiology of Disease.

[39]  K. Ikeda,et al.  Prevention by insulin-like growth factor-I and riluzole in motor neuron death after neonatal axotomy , 1999, Journal of the Neurological Sciences.

[40]  M. Gurney,et al.  Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis , 1999, Neuroscience.

[41]  S. Przedborski,et al.  Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.

[42]  C. Epstein,et al.  Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia , 1998, Annals of neurology.

[43]  M. Gurney,et al.  Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS , 1998 .

[44]  V. Barrios,et al.  The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis , 1998, Neurology.

[45]  L. Barbeito,et al.  Nitric Oxide and Superoxide Contribute to Motor Neuron Apoptosis Induced by Trophic Factor Deprivation , 1998, The Journal of Neuroscience.

[46]  M. Gurney,et al.  Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. , 1998, Glia.

[47]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[48]  C. Epstein,et al.  Brain Injury after Perinatal Hypoxia-Ischemia Is Exacerbated in Copper/Zinc Superoxide Dismutase Transgenic Mice , 1996, Pediatric Research.

[49]  G. Wilkin,et al.  Neural cell culture: a practical approach , 1995 .

[50]  P. Sinet,et al.  Hippocampal mossy fiber changes in mice transgenic for the human copper-zinc superoxide dismutase gene , 1993, Neuroscience Letters.

[51]  J. Tajti,et al.  Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. , 1993, Archives of neurology.

[52]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .